News

OTP login is now standard in Castor’s eConsent platform. No account setup or passwords to create. Participants receive a one-time code, enter it, and move straight into the study flow—landing page, screener, consent. The result: >98% screener completion in a recent real-world study. Castor doesn’t treat login as an afterthought. This is built-in, not bolted on. If your platform still relies on email links and account creation, you’re losing participants before the study even starts.

Castor and LLS launch a study using AI and remote blood sampling to improve care for patients with leukemia and lymphoma.

Castor has announced free access to its clinical trial technology platform for U.S. researchers impacted by recent NIH funding cuts. Through the Castor for Impact Program, investigators can maintain data integrity, streamline workflows, and keep projects moving forward, despite reduced indirect cost allocations threatening vital scientific progress and ongoing discovery.

Innovative Program Offers Discounted or Free Access to Clinical Trial Technology, Empowering Underserved Research Areas and Early-Stage Biotech and Medical Device Companies

The partnership will streamline the synchronization of clinical trial and real-world data throughout the clinical research stages.

The partnership will streamline the synchronization of clinical trial and real-world data throughout the clinical research stages.

The latest report from Industry Standard Research (ISR) Sheds Light on eCOA/ePRO Market Dynamics. The Performance of Castor Shines Through.

Today, Castor announces its collaboration with Microsoft to integrate Practical AI in clinical trials, reducing trial burdens for patients & sites.

His exceptional leadership experience and extensive industry knowledge in the healthcare and technology industries will be invaluable to Castor